Breaking News
Dubai: cryptocurrency payments for government services thanks to Crypto.com
Shocking UFO files hidden in presidential library claim US made successful contact with an alien...
Southern state residents 'desperate to escape' but homes won't sell as crash looms
Trump blasts hysteria over Qatar's $400M gift: 'We're the USA'
Top Tech News
Cab-less truck glider leaps autonomously between road and rail
Can Tesla DOJO Chips Pass Nvidia GPUs?
Iron-fortified lumber could be a greener alternative to steel beams
One man, 856 venom hits, and the path to a universal snakebite cure
Dr. McCullough reveals cancer-fighting drug Big Pharma hopes you never hear about…
EXCLUSIVE: Raytheon Whistleblower Who Exposed The Neutrino Earthquake Weapon In Antarctica...
Doctors Say Injecting Gold Into Eyeballs Could Restore Lost Vision
Node without Consent
Dark Matter: An 86-lb, 800-hp EV motor by Koenigsegg
Spacetop puts a massive multi-window workspace in front of your eyes
Finally Confirmed! Vitamin D Nearly Abolishes ICU Risk in COVID-19
The First Randomized Controlled Trial on Vitamin D and COVID-19
The trial was conducted at the Reina Sofi?a University Hospital in Co?rdoba, Spain. The trial included 76 patients with COVID-19 pneumonia. Although this is no longer the standard of care, all patients were treated with hydroxychloroquine and azithromycin and, when needed, a broad-spectrum antibiotic. Admission to the ICU was determined by a multidisciplinary committee consisting of intensive care specialists, pulmonologists, internal medicine specialists, and members of the ethics committee.
The patients were randomly allocated to receive or not receive vitamin D in a 2:1 ratio. This resulted in 50 patients in the vitamin D group and 26 patients in the control group.